Literature DB >> 24030285

Increased active PTH(1-84) fraction as a predictor of poor mortality in male hemodialysis patients.

M Inaba1, S Okuno, Y Imanishi, E Ishimura, T Yamakawa, S Shoji.   

Abstract

UNLABELLED: We reported previously that serum parathyroid hormone [PTH(1-84)]/intact PTH[PTH(1-84) + PTH(7-84)] ratio provides the better marker for parathyroid function and bone turnover state than serum PTH level itself. The present study demonstrated that higher PTH(1-84)/intact PTH ratio, but not serum PTH(1-84) and intact PTH, predicted higher all-cause mortality in 177 male hemodialysis patients.
INTRODUCTION: We reported that PTH(1-84)/intact PTH ratio provides a clinically relevant marker for parathyroid function and the resultant bone turnover state. The purpose of our study was to investigate the association of PTH(1-84)/intact PTH ratio with all-cause mortality (ACM) in male hemodialysis patients.
METHODS: The study was performed for 70 months. Serum PTH in 177 male hemodialysis patients was measured with PTH(1-84)-specific whole PTH assay and intact PTH assay which cross-reacts with N-truncated PTH including PTH(7-84).
RESULTS: The patients (n = 177) were divided into higher and lower halves based on serum levels of PTH(1-84)/intact PTH ratio (cutoff value, 0.484), intact PTH (143.8 pg/mL), and PTH(1-84) (64.1 pg/mL). In Kaplan-Meier analysis, the higher group in whole PTH/intact PTH ratio had significantly higher ACM than the lower group (P = 0.020 by log-rank test), in contrast with the insignificant difference between the higher and lower groups in intact PTH and PTH(1-84). Multivariate Cox regression hazard analysis identified higher log [PTH(1-84)/intact PTH ratio], but not log intact PTH or log PTH(1-84) as a significant independent predictor [hazard ratio 14.428 (95% CI 2.486-83.728)] for ACM after adjustment for various factors including age, hemodialysis duration, presence/absence of diabetes mellitus, BMI, log C-reactive protein, serum albumin, calcium, and phosphate. The association existed between log [PTH(1-84)/intact PTH ratio] and ACM in those without vitamin D administration (n = 95).
CONCLUSION: Higher PTH(1-84)/intact PTH ratio, which provides a relevant marker for parathyroid function, may be a significant predictor of ACM in male hemodialysis patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24030285     DOI: 10.1007/s00198-012-2245-x

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  32 in total

1.  Technical and clinical characterization of the Bio-PTH (1-84) immunochemiluminometric assay and comparison with a second-generation assay for parathyroid hormone.

Authors:  Masaaki Inaba; Kiyoshi Nakatsuka; Yasuo Imanishi; Masakazu Watanabe; Yuji Mamiya; Eiji Ishimura; Yoshiki Nishizawa
Journal:  Clin Chem       Date:  2003-12-18       Impact factor: 8.327

2.  Reduction of whole PTH/intact PTH ratio as a predictor of bone metabolism in cinacalcet treatment of hemodialysis patients with secondary hyperparathyroidism.

Authors:  M Kurajoh; M Inaba; S Okuno; H Nagayama; S Yamada; Y Imanishi; E Ishimura; S Shoji; T Yamakawa; Y Nishizawa
Journal:  Osteoporos Int       Date:  2010-05-07       Impact factor: 4.507

3.  Serum albumin as a predictor of mortality in peritoneal dialysis: comparisons with hemodialysis.

Authors:  Rajnish Mehrotra; Uyen Duong; Sirin Jiwakanon; Csaba P Kovesdy; John Moran; Joel D Kopple; Kamyar Kalantar-Zadeh
Journal:  Am J Kidney Dis       Date:  2011-05-20       Impact factor: 8.860

4.  Association between very low PTH levels and poor survival rates in haemodialysis patients: results from the French ARNOS cohort.

Authors:  G Jean; D Lataillade; L Genet; E Legrand; F Kuentz; X Moreau-Gaudry; D Fouque
Journal:  Nephron Clin Pract       Date:  2010-12-17

5.  Protective effect of an aldose reductase inhibitor against bone loss in galactose-fed rats: possible involvement of the polyol pathway in bone metabolism.

Authors:  M Inaba; M Terada; Y Nishizawa; A Shioi; E Ishimura; S Otani; H Morii
Journal:  Metabolism       Date:  1999-07       Impact factor: 8.694

6.  Higher serum bone alkaline phosphatase as a predictor of mortality in male hemodialysis patients.

Authors:  Ikue Kobayashi; Kaori Shidara; Senji Okuno; Shinsuke Yamada; Yasuo Imanishi; Katsuhito Mori; Eiji Ishimura; Shigeichi Shoji; Tomoyuki Yamakawa; Masaaki Inaba
Journal:  Life Sci       Date:  2011-12-01       Impact factor: 5.037

7.  Different risk factors for peripheral vascular calcification between diabetic and non-diabetic haemodialysis patients--importance of glycaemic control.

Authors:  E Ishimura; S Okuno; K Kitatani; M Kim; T Shoji; T Nakatani; M Inaba; Y Nishizawa
Journal:  Diabetologia       Date:  2002-08-16       Impact factor: 10.122

8.  Cinacalcet suppresses calcification of the aorta and heart in uremic rats.

Authors:  Takehisa Kawata; Nobuo Nagano; Masaki Obi; Sonoe Miyata; Chika Koyama; Nami Kobayashi; Sachiko Wakita; Michihito Wada
Journal:  Kidney Int       Date:  2008-08-27       Impact factor: 10.612

9.  Significance of Bio-intact PTH(1-84) assay in hemodialysis patients.

Authors:  Masaaki Inaba; Senji Okuno; Yasuo Imanishi; Misako Ueda; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Journal:  Osteoporos Int       Date:  2004-08-20       Impact factor: 4.507

10.  Influence of PTH assay methodology on differential diagnosis of renal bone disease.

Authors:  Helmut Reichel; Angela Esser; Heinz-Jürgen Roth; Heinrich Schmidt-Gayk
Journal:  Nephrol Dial Transplant       Date:  2003-04       Impact factor: 5.992

View more
  2 in total

Review 1.  Pharmacological Management of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease.

Authors:  S N Salam; A Khwaja; M E Wilkie
Journal:  Drugs       Date:  2016-05       Impact factor: 9.546

2.  Effects of parathyroidectomy on plasma PTH fragments and heart rate variability in stage 5 chronic kidney disease patients.

Authors:  Huimin Chen; Wenkai Ren; Zhanhui Gao; Ming Zeng; Shaowen Tang; Fangyan Xu; Yaoyu Huang; Lina Zhang; Ying Cui; Guang Yang; Hanyang Qian; Wenbin Zhou; Chun Ouyang; Xueyan Gao; Jing Zhang; Yujie Xiao; Baiqiao Zhao; Jing Wang; Anning Bian; Fan Li; Huiting Wan; Wei Gao; Xiaoyun Wang; Changying Xing; Xiaoming Zha; Ningning Wang
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.